H-CYTE, Inc Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Subsequent Events (Details Narrative) - USD ($)		9 Months Ended
	Sep. 29, 2022	Sep. 30, 2022	Sep. 30, 2021
Proceeds from issuance of common stock		$ 225,001
Purchase Agreement Member
Stock issued during period shares new issues	112,500
Stock issued during period shares new issues		$ 2.50
Proceeds from issuance of common stock		$ 30,000
Common Stock [Member] \| Purchase Agreement Member
Stock issued during period shares new issues		15,000
Warrant [Member] \| Purchase Agreement Member
Stock issued during period shares new issues		7,250